Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature

Peer Review reports

Original Submission
2 May 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
22 Jun 2013	Reviewed	Reviewer Report - Pashtoon Murtaza Kasi
16 Aug 2013	Reviewed	Reviewer Report - Dina Attias
21 Sep 2013	Author responded	Author comments - Haruki Kume
Resubmission - Version 3
21 Sep 2013	Submitted	Manuscript version 3
Publishing
30 Sep 2013	Editorially accepted
30 Dec 2013	Article published	10.1186/1752-1947-7-280

Back to article page